Eisai, Biogen get U.S. FDA approval for Alzheimer's drug, apply for full approval – Reuters
Business News
- Eisai, Biogen get U.S. FDA approval for Alzheimer’s drug, apply for full approval Reuters
- FDA Approves, Leqembi, New Treatment for Early Alzheimer’s The New York Times
- FDA greenlights new Alzheimer’s drug amid safety concerns NBC News
- Alzheimer’s drug lecanemab receives accelerated approval amid safety concerns CNN
- New Alzheimer’s drug offers hope to patients and caregivers | DW News DW News
- View Full Coverage on Google News
Source: Business News